Primary practice
Oncology Of Northshore Clinic
Primary care practice · Rolling Meadows, Illinois
Find Dr. Rosado's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Rosado practices at Oncology Of Northshore Clinic in Rolling Meadows, Illinois.
Dr. Rosado's NPI, 1134228760, was assigned on September 21, 2006. Dr. Rosado holds Illinois license 036122699.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Rosado's primary practice is Oncology of Northshore Clinic, at 2000 Golf Rd, Rolling Meadows, IL 60008-4216. The practice phone is (847) 871-1800.
Source: Dmand AI Affiliation Data
Dr. Rosado's primary practice is Oncology Of Northshore Clinic in Rolling Meadows, Illinois. Dr. Rosado is also affiliated with Evanston Hospital. The medical group on file is Oncology of Northshore. Dmand AI also links Dr. Rosado to 3 more hospitals, each named with a free account.
Source: Dmand AI Affiliation Data
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rosado practices, 5 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Oncology Of Northshore Clinic | Available with a free account |
| +4 more affiliated sites | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Hematology and oncology is Dr. Rosado's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Rosado is licensed in Illinois.
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
CMS data shows 25,021 Medicare services from Dr. Rosado across 30 procedure codes in 2024, for 370 Medicare patients. Medicare paid $184,438 for them.
Medians across 547 hematologists and oncologists in Illinois with Dmand AI profiles that report each measure.
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Rosado?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Rosado and other hematologists and oncologists in Illinois.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
CMS counts 370 Medicare patients who saw Dr. Rosado in 2024. The largest group is 75 to 84, with 151 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 21% are also on Medicaid. Their average risk score is 1.93, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Rosado's median patient age at 71, with 51% women.
Share of Medicare patients with each condition. A patient can have several.
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Median age 71
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
In 2024, Dr. Rosado wrote 1,847 Medicare Part D claims for 242 patients. 60% of them were for generic drugs. CMS names the drug for 1,501 of them, across 41 drugs with 11 or more claims each, at $7,428,385 in total drug cost. In 2023, CMS named 1,376 claims across 43 drugs.
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Drugs named by CMS: 41 in 2024, 43 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 98 out of 100 for Dr. Rosado for performance year 2024, reported individually. Dr. Rosado accepts Medicare assignment, so Medicare's approved amount is taken as full payment.
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dmand AI links Dr. Rosado to 1 clinical trial. Conditions studied include Carcinoma, Non-Small-Cell Lung and Carcinoma, Bronchogenic.
Conditions in Dr. Rosado's trials
Sources: ClinicalTrials.gov (National Library of Medicine); and Dmand AI Research Linkage
CMS Open Payments shows 671 general payments to Dr. Rosado from 60 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 95% of the total. Novartis Pharmaceuticals Corporation paid the most, $1,535.
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Clinical trials and co-investigators | ClinicalTrials.gov (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
Dr. Manuel Francisco Rosado's NPI number is 1134228760. It was assigned on September 21, 2006, and it is active in the NPI Registry.
Dr. Manuel Francisco Rosado is a hematologist and oncologist in Rolling Meadows, Illinois. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Dr. Rosado practices at 2000 Golf Rd, Rolling Meadows, IL 60008-4216. Dr. Rosado's primary practice is Oncology Of Northshore Clinic in Rolling Meadows, Illinois. Dmand AI also links Dr. Rosado to 3 hospitals.
The practice phone on file for Dr. Rosado is (847) 871-1800.
Dr. Rosado holds Illinois license 036122699.
Dr. Rosado is affiliated with Evanston Hospital. Dmand AI links Dr. Rosado to 3 more hospitals.
Dr. Rosado is linked to Oncology of Northshore.
Yes. CMS data shows Dr. Rosado billed Medicare for 25,021 services in 2024, and Dr. Rosado accepts Medicare assignment.
Dr. Rosado's MIPS final score for performance year 2024 is 98 out of 100, reported individually.
CMS counts 370 Medicare patients who saw Dr. Rosado in 2024, with an average age of 77.
In 2024, Dr. Rosado's most billed Medicare services were injected or infused drug (J1453), injected or infused drug (J1100) and injected or infused drug (J2405).
In 2024 Medicare Part D data, Dr. Rosado's most prescribed drugs by claims were Eliquis, Lenalidomide and Acyclovir.
CMS Open Payments shows $11,588 in general payments to Dr. Rosado from 60 companies from 2016 to 2025. The largest total came from Novartis Pharmaceuticals Corporation.
Dr. Rosado graduated from medical school in 1993, 33 years ago.
Dr. Rosado has worked on 1 clinical trial.
Selling to hematology and oncology practices?
See hematologists and oncologists in Illinois by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.